IBIO, INC. (IBIO) Current Ratio
- Current ratio · latest quarter: Value 7.85×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 7.85× | Current assets / current liabilities. $92.22M ÷ $11.74M ≈ 7.85× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 92.22M USD | Assets, Current |
| Current obligations | 11.74M USD | Liabilities, Current |
| Cash and equivalents | 56.40M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 31.64M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 4.42M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $92.22M | $11.74M | $56.40M | $31.64M | (m) | (m) | $4.42M | (m) | 7.85× |
| 2026-03-31 | $77.25M | $6.50M | $47.63M | $27.19M | (m) | (m) | $3.04M | (m) | 11.88× |
| 2025-12-31 | $53.37M | $5.90M | $28.67M | $24.02M | (m) | (m) | $2.65M | (m) | 9.04× |
| 2025-09-30 | $50.77M | $6.05M | $28.11M | $21.47M | $65.00K | (m) | $2.82M | (m) | 8.39× |
| 2025-06-30 | $9.72M | $6.11M | $8.58M | (m) | (m) | (m) | $2.19M | (m) | 1.59× |
| 2025-03-31 | $6.06M | $5.40M | $4.96M | (m) | (m) | (m) | $1.48M | (m) | 1.12× |
| 2024-12-31 | $8.29M | $4.71M | $7.01M | (m) | (m) | (m) | $614.00K | (m) | 1.76× |
| 2024-09-30 | $11.71M | $3.47M | $11.04M | (m) | (m) | (m) | $855.00K | (m) | 3.37× |
| 2024-06-30 | $15.67M | $3.84M | $14.21M | (m) | (m) | (m) | $358.00K | (m) | 4.08× |
| 2024-03-31 | $36.14M | $21.43M | $5.30M | (m) | (m) | $0.00 | $1.23M | (m) | 1.69× |
| 2023-12-31 | $19.70M | $21.55M | $2.79M | (m) | (m) | $0.00 | $1.86M | (m) | 0.91× |
| 2023-09-30 | $23.02M | $20.71M | $1.46M | (m) | $0.00 | $0.00 | $1.91M | (m) | 1.11× |
| 2023-06-30 | $26.26M | $22.11M | $4.30M | (m) | (m) | $0.00 | $1.85M | (m) | 1.19× |
| 2023-03-31 | $27.09M | $22.28M | $6.56M | (m) | $70.00K | (m) | $2.01M | (m) | 1.22× |
| 2022-12-31 | $38.23M | $27.77M | $3.70M | (m) | $970.00K | (m) | $4.00M | (m) | 1.38× |
| 2022-09-30 | $63.56M | $32.20M | $9.89M | (m) | $1.05M | (m) | $4.81M | (m) | 1.97× |
| 2022-06-30 | $45.07M | $30.44M | $22.68M | (m) | $1.00M | $3.90M | $4.26M | (m) | 1.48× |
| 2022-03-31 | $60.32M | $8.28M | $33.77M | (m) | $1.00M | $3.28M | $5.28M | (m) | 7.28× |
| 2021-12-31 | $67.50M | $8.35M | $39.20M | (m) | $111.00K | $1.99M | $2.74M | (m) | 8.09× |
| 2021-09-30 | $89.82M | $8.10M | $62.82M | (m) | $207.00K | $587.00K | $2.29M | (m) | 11.09× |
| 2021-06-30 | $104.60M | $6.64M | $77.40M | (m) | $426.00K | $27.00K | $2.25M | (m) | 15.74× |
| 2021-03-31 | $107.20M | $6.07M | $84.63M | (m) | $387.00K | (m) | $1.63M | (m) | 17.67× |
| 2020-12-31 | $110.88M | $6.10M | $91.25M | (m) | $180.00K | (m) | $2.41M | (m) | 18.17× |
| 2020-09-30 | $84.96M | $5.05M | $77.54M | (m) | $300.00K | (m) | $1.60M | (m) | 16.84× |
| 2020-06-30 | $61.75M | $5.24M | $55.11M | (m) | $75.00K | (m) | $1.76M | (m) | 11.79× |
| 2019-12-31 | $4.01M | $4.74M | $3.64M | (m) | $224.00K | (m) | $442.00K | (m) | 0.84× |
| 2019-09-30 | $2.36M | $4.87M | $2.10M | (m) | $75.00K | (m) | $661.00K | (m) | 0.48× |
| 2019-06-30 | $4.81M | $3.46M | $4.42M | (m) | $97.00K | (m) | $1.00M | (m) | 1.39× |
| 2019-03-31 | $9.59M | $4.05M | $9.04M | (m) | $117.00K | (m) | $722.00K | (m) | 2.37× |
| 2018-12-31 | $13.97M | $4.45M | $13.36M | (m) | $155.00K | (m) | $662.00K | (m) | 3.14× |
| 2018-09-30 | $16.34M | $5.04M | $16.01M | (m) | $119.00K | (m) | $692.00K | (m) | 3.24× |
| 2018-06-30 | $16.29M | $2.04M | $15.93M | (m) | $75.00K | (m) | $790.00K | (m) | 8.00× |
| 2018-03-31 | $3.99M | $1.95M | $3.40M | (m) | $181.00K | (m) | $939.00K | (m) | 2.05× |
| 2017-12-31 | $7.82M | $2.04M | $7.31M | (m) | $136.00K | (m) | $701.00K | (m) | 3.83× |
| 2017-09-30 | $6.38M | $2.11M | $5.92M | (m) | $260.00K | (m) | $596.00K | (m) | 3.03× |
| 2017-06-30 | $8.57M | $2.01M | $8.09M | (m) | $175.00K | (m) | $749.00K | (m) | 4.26× |
| 2017-03-31 | $12.98M | $2.62M | $12.42M | (m) | $128.00K | (m) | $1.39M | (m) | 4.95× |
| 2016-12-31 | $16.75M | $1.87M | $16.33M | (m) | $25.00K | (m) | $731.00K | (m) | 8.97× |
| 2016-09-30 | $20.46M | $2.17M | $20.10M | (m) | $170.00K | (m) | $979.00K | (m) | 9.41× |
| 2016-06-30 | $23.91M | $2.29M | $23.01M | (m) | $484.00K | (m) | $1.18M | (m) | 10.43× |
| 2016-03-31 | $22.72M | $2.44M | $21.89M | (m) | $454.00K | (m) | $1.55M | (m) | 9.31× |
| 2015-06-30 | $10.12M | $1.26M | $9.49M | (m) | $445.00K | (m) | $1.10M | (m) | 8.01× |
| 2014-12-31 | $8.56M | $1.48M | $7.36M | (m) | $584.00K | (m) | $984.00K | (m) | 5.80× |
| 2014-09-30 | $4.12M | $1.22M | $3.49M | (m) | $0.00 | (m) | $516.00K | (m) | 3.38× |
| 2014-03-31 | $5.53M | $1.21M | $4.33M | (m) | $1.01M | (m) | $1.12M | (m) | 4.56× |
| 2013-12-31 | $6.94M | $1.66M | $5.68M | (m) | $1.01M | (m) | $1.25M | (m) | 4.17× |
| 2013-09-30 | $4.64M | $1.65M | $3.44M | (m) | $1.01M | (m) | $1.31M | (m) | 2.81× |
| 2013-06-30 | $6.63M | $4.29M | $4.41M | (m) | $1.01M | (m) | $2.40M | (m) | 1.55× |
| 2013-03-31 | $2.21M | $2.68M | $1.53M | (m) | $390.19K | (m) | $2.42M | (m) | 0.82× |
| 2012-12-31 | $4.00M | $3.09M | $2.82M | (m) | $390.19K | (m) | $2.71M | (m) | 1.29× |
| 2012-09-30 | $5.15M | $3.42M | $4.28M | (m) | $390.19K | (m) | $2.42M | (m) | 1.51× |
| 2012-06-30 | $6.90M | $3.60M | $5.62M | (m) | $351.00K | (m) | $2.85M | (m) | 1.92× |
| 2012-03-31 | $7.68M | $3.80M | $6.72M | (m) | $371.75K | (m) | $2.18M | (m) | 2.02× |
| 2011-12-31 | $1.94M | $4.71M | $623.45K | (m) | $233.83K | (m) | $4.04M | (m) | 0.41× |
| 2011-09-30 | $2.53M | $4.69M | $1.52M | (m) | $320.35K | (m) | $2.98M | (m) | 0.54× |
| 2011-06-30 | $4.30M | $7.14M | $2.84M | (m) | $344.08K | (m) | $2.90M | (m) | 0.60× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |